Association between selected cholesterol-related gene polymorphisms and Alzheimer's disease in a Turkish cohort

GUVEN G. , Vurgun E., Bilgic B. , HANAGASI H. A. , Gurvit H. , Özer E., ...Daha Fazla

MOLECULAR BIOLOGY REPORTS, cilt.46, ss.1701-1707, 2019 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 46 Konu: 2
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1007/s11033-019-04619-8
  • Sayfa Sayıları: ss.1701-1707


Numerous genetic evidence has pointed out that variations in cholesterol-related genes may be associated with an Alzheimer's disease (AD) risk. We aimed to investigate the association between polymorphisms in several cholesterol-related genes [APOA5 (rs662799), APOC1 (rs11568822), APOD (rs1568565), CH25H (rs13500), LDLR (rs5930), SORL1 (rs2282649)] and AD in a cohort of Turkish patients. The study group consisted of 257AD patients (mean age: 75.9years +/- 10.4) and 414 controls (mean age: 62.2years +/- 13.1). Genotyping was performed by quantitative real-time polymerase chain reaction using hydrolysis probes. Our results showed that the TT' genotype of CH25H rs13500 polymorphism was significantly more frequent in the AD group (p<0.001) and individuals carrying the CH25H T' allele had an increased risk for AD (OR 3.07, 95% CI 2.13-4.44, p=2.20e-09) independently from age, gender and APOE epsilon 4 allele. Moreover, this risk was excessively increased (OR 14.04, 95% CI 6.99-28.23, p=9.78e-14) in the presence of APOE epsilon 4 allele. The ins/ins' genotype of APOC1 rs11568822 was significantly more frequent in the AD group compared to controls (p=1.95e-08). However, this increased AD risk in ins/ins' carriers was found to be dependent on their APOE epsilon 4 carrier status. No significant associations were found in allele and genotype distributions of APOA5, APOD, LDLR and SORL1 gene polymorphisms. Our results suggest that the association between APOC1 ins/ins' genotype and AD risk can be explained by linkage disequilibrium with the APOE locus. CH25H rs13500 polymorphism is associated with an AD risk in the Turkish population and CH25H might have a role in the pathogenesis of AD together with, and independently from APOE.